CIRG has been featured in the NHS Lothian Connections newsletter on pages 4 and 5 with a focus on GeoSentinel !

Happy International Nurses Day to all our nurses

Keep up with what the team are doing by checking our our Bluesky page

CIRG is always looking for healthy volunteers to become involved in studies

Congratulations to CIRG members, Anna Gordon and Claire Mackintosh, on their recent publication

Congratulations to our former research fellow Alexandria Chung and Clinical Director of RIDU Claire Mackintosh on their recent publication on addressing the needs of people who inject drugs

We are now looking for our Clinical Research Fellow for 2025-2026 !!

We are excited to share all the amazing research done by our talented CIRG members.

Results of the SUPERNOVA trial, worked on by Dr Oliver Koch and the CIRG team, have been published in The Lancet.

Read our CIRG review of the year

Angus McCance joins CIRG

The antimicrobial management team have had 3 abstracts published in JAC-AMR

CIRG members attending the Edinburgh Infectious Disease Symposium

Dr Mackintosh has recently published 2 articles

Dr Ian Laurenson is one of a global collection of Drs to write a new paper guiding best practice public health standards for whole genome sequencing of Mycobacterium tuberculosis

Dr Olga Lucia Moncayo-Nieto has a new paper published ‘Extrapulmonary nontuberculous mycobacterial infections: a guide for the general physician’ in the journal of Clinical Medicine

CIRG is always looking for healthy volunteers to become involved in studies – and is now actively recruiting!

CIRG’s Annual Review 2022-2023

A free, in person Infection Trainee Research day on Wednesday 8th November 2023

Carol Phllips’ reflection and overvew of their attendence at the BSAC UTI Conference

Carol Philip supported by CIRG fund

16th June 2023 is #Red4Research

The VIBRANT study has collected all of it’s required 200 samples

Dr Hopkin’s shares his experience after completing the NIHR Associate Principal Investigator Scheme for our CIRG run project “Improving Outcomes in Necrotising Otitis Externa (IONOE)”

CIRG supports Dr Sugrue in attending the ECCMID Conference

The results from the Valneva vaccine trial have been published in The Lancet! Dr. Iain Page is mentioned as one of the Valneva phase 3 trial group

A fascinating paper recently published in The Journal of Viral Hepatitis. The paper features WGH’s Senior Clinical Pharmacist, Katherine Davidson as one of the paper’s authors

CIRG has started recruiting to two new exciting studies

CIRG Study Coordinator Sheila takes part in project documenting nurses experience of working in the AIDS Era

GIRG’s Research Coordinator and Lead Nurse, Sheila Morris, gives her account of leading an ID research team during the COVID-19 pandemic in this webinar recording

New Results from the RECOVERY Trial suggest that baricitinib can reduce the risk of death in hospitalised COVID-19 patients

Two recently published papers authored by CIRG members

‘Clinicians and researchers must advocate for evidence based drug policy’

Daptomycin susceptibility testing and therapeutic use in enterococcal bloodstream infection (EBSI) in a setting with high rates of vancomycin-resistant Enterococcus faecium (VREfm)

Keep up to date with the latest clinical research on COVID-19 with this exciting seminar series organised by the HEAL-COVID trial team

Our Clinical Director, Dr Claire Mackintosh, took part in this creative exploration of the early stages of the pandemic through the eyes of frontline staff in the homelessness sector and people experiencing homelessness

CIRG members recently attended Federation of Infection Societies 2021 Annual Conference (FIS 2021)

CIRG members will be presenting their work at the upcoming Federation of Infection Societies 2021 Annual Conference (FIS 2021) in Manchester (5 November) and Online 8 and 9 November 2021

Using cutting-edge genomic sequencing techniques, researchers from the CRyPTIC consortium have identified almost all the genomic variation that gives people resistance to 13 of the most common tuberculosis (TB) drug treatments

Valneva Reports Positive Phase III Trial Results for their Inactivated, Adjuvanted COVID-19 Vaccine Candidate VLA2001

Alice Hailwood recently presented her work with CIRG member Sandeep Ramalingam, in collaboration with colleagues from University of Edinburgh at the 31st European Congress of Clinical Microbiology & Infectious Diseases (ECCMID)

Analysis of hospital sewage favourably reviewed in Frontiers of Medical Microbiology

This new trial aiming to impact on long-term effects of COVID-19 has begun recruiting at the Royal Infirmary Edinburgh, Western General Hospital, and St John’s Hospital

Further therapeutic options for COVID-19

More accolades for this novel trial!

AZD2816 is a modified version of the Oxford/AstraZeneca COVID-19 vaccine, that has been made specific for the Beta SARS CoV-2 variant

Striving for equity helps to promote excellence

RECOVERY trial finds aspirin does not improve survival for patients hospitalised with COVID-19

A phase III trial of Valneva’s new COVID-19 vaccine is now up and running here in Edinburgh